EPN (Biotechnology) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Out of Business

EPN (Biotechnology) General Information

Description

Manufacturer of molecular diagnostic products designed to support personalised healthcare and early disease detection through genetic and epigenetic analysis. The company offers gene testing technologies, epigenetic biomarker detection platforms and precision diagnostic capabilities, enabling healthcare providers and clinical laboratories to identify disease indicators, improve diagnostic accuracy and support individualised treatment decisions.

Contact Information

Website
www.epican.cn
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Number 500 Huapu Road
  • Qingpu District
  • Shanghai, 201799
  • China
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Corporate Office
  • Number 500 Huapu Road
  • Qingpu District
  • Shanghai, 201799
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EPN (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jan-2023 Completed Out of Business
4. Secondary Transaction - Private 20-Dec-2017 Completed Generating Revenue
3. Early Stage VC (Series B) 01-May-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Jul-2016 $5.34M $6.92M Completed Generating Revenue
1. Seed Round 02-Nov-2015 $1.57M $1.57M Completed Startup
To view EPN (Biotechnology)’s complete valuation and funding history, request access »

EPN (Biotechnology) Patents

EPN (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019149093-A1 Gene marker for detecting esophageal cancer, use thereof and detection method therefor Inactive 05-Feb-2018
WO-2019024578-A1 Gene marker for detecting benign and malignant liver tumors, kit and detection method Inactive 04-Aug-2017
WO-2019024579-A1 Gene marker for detecting lung cancer, kit and lung cancer detection method Inactive 04-Aug-2017
WO-2018228028-A1 Gene marker for use in detecting liver cancer and use thereof Inactive 16-Jun-2017
WO-2018228029-A1 Gene marker for use in detecting liver cancer and use thereof Inactive 16-Jun-2017 C12Q1/6886
To view EPN (Biotechnology)’s complete patent history, request access »

EPN (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EPN (Biotechnology) FAQs

  • When was EPN (Biotechnology) founded?

    EPN (Biotechnology) was founded in 2015.

  • Where is EPN (Biotechnology) headquartered?

    EPN (Biotechnology) is headquartered in Shanghai, China.

  • What is the size of EPN (Biotechnology)?

    EPN (Biotechnology) has 29 total employees.

  • What industry is EPN (Biotechnology) in?

    EPN (Biotechnology)’s primary industry is Biotechnology.

  • Is EPN (Biotechnology) a private or public company?

    EPN (Biotechnology) is a Private company.

  • What is EPN (Biotechnology)’s current revenue?

    The current revenue for EPN (Biotechnology) is .

  • How much funding has EPN (Biotechnology) raised over time?

    EPN (Biotechnology) has raised $6.92M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process